Your browser is old and is not supported. Upgrade for better security.

Invest in BioSmart Research, Inc.

BioSmart Research: Invest in the future of cannabinoid therapy

Pitch Video
Investor Panel

Highlights

1
Launch in 2019 produced $1.7M in sales
2
Biosmart produces pain management and anti-anxiety formulas for clinical and retail distribution
3
BioSmart has a 3-year technology lead using high-pressure liquid chromatography for isolate extraction
4
BioSmart markets through it's own retail dispensaries, healthcare providers, pharmacies, affiliates, and internet sales
5
U.S. Market for non-steroidal OTC pain relievers is $21.9 B/yr. US CBD market is $4.7 B/yr.
6
Clinical dosing levels with CBD isolates produce similar results to OTC pain relievers without the side effects.
7
BioSmart collaborates with university and clinical researchers and is a member of Choose Wisely, a patient forum
8
BioSmart Research represents a responsible approach to improving quality of life and advancing cannabinoid research

Our Founder

We went this direction in our research and development because we saw a huge gap in the research and development of effective CBD products. We decided to pursue a scientific and clinical approach to the development of CBD nutraceuticals. Isolate extraction and product formulation are where the wave in product development is headed.

Pitch

Disclaimer: These projections cannot be guaranteed

Disclaimer: These projections cannot be guaranteed


Downloads

Overview